An Act Defining Breast Ultrasound As A Screening Procedure For Insureds.
Summary
SB 450 is a short bill that would amend Connecticut General Statutes sections 38a-503 and 38a-530 to define breast ultrasound as a screening procedure for insureds. The practical effect is to place breast ultrasound within the category of screening services recognized under the insurance statutes, rather than leaving its status ambiguous or treating it solely as a diagnostic test.
By doing so, the bill could affect how health insurance plans cover and pay for breast ultrasound services, particularly in contexts where screening services receive different coverage treatment than diagnostic procedures. The bill is aimed at insured individuals and would primarily affect health insurers, policyholders, and providers that order or perform breast imaging services.
Impact
The bill would amend existing insurance statutes governing coverage and related requirements by expressly including breast ultrasound as a screening procedure. This could influence benefit design, coverage determinations, and cost-sharing rules for breast imaging under state-regulated health plans, depending on how the amended statutes are implemented and interpreted. It would most directly affect insured patients seeking breast ultrasound, as well as insurers and medical providers involved in breast cancer screening and imaging services.
Sentiment
No committee transcript or vote record is available for this bill, so there is no direct evidence of support or opposition in the provided materials. Based on the bill text alone, the measure appears narrowly targeted and policy-focused, with an apparent intent to improve access to breast screening services for insureds. The available record does not show any recorded controversy or formal debate.
Contention
Because there are no transcripts or votes provided, no specific points of contention are documented in the record. Potential issues that could arise in discussion of a bill like this include whether breast ultrasound should be treated as a screening versus diagnostic service, how insurers would be required to cover it, and whether the change could affect premiums or utilization. However, these concerns are not attributed to any identified person or group in the supplied materials.